Latest news and articles about obesity from NEX English
France has announced that it will start reimbursing the costs of weight loss medications such as 'Wegovy' and 'Monjaro' from June 15, making it the first country in Europe to adopt this measure. This initiative reflects the French government's commitment to improving the health of its citizens.
Processed foods remain a significant threat to public health, even with the emergence of medications like Ozempic aimed at combating obesity. Studies indicate that these foods contribute to the rise of chronic diseases, prompting a reevaluation of our dietary habits.
A recent study reveals that walking approximately <strong>8500 steps daily</strong> is essential for individuals aiming to lose weight and maintain their results. The research emphasizes the significance of physical activity in weight loss programs.
A nutritionist has warned about the health risks associated with rapid diets and weight loss injections, stating that these methods can lead to serious side effects. The expert emphasized that quick weight loss may have negative consequences for overall health, including an increased risk of heart disease and diabetes.
Researchers indicate that individuals who have lost weight and wish to maintain it should walk approximately <strong>8500 steps daily</strong>. A new study highlights that increased physical activity plays a crucial role in preventing weight regain.
Early obesity is more than just weight gain; it marks the onset of silent health risks that accumulate over time. Understanding the impact of weight gain during youth is crucial for public health.
Eating late at night can lead to digestive disturbances and uncomfortable symptoms. Experts warn about the effects of this habit on gut health and blood sugar levels.
Recent research shows that fat cells retain memories of obesity long after weight loss, complicating efforts to maintain ideal body weight. This finding highlights the biological challenges faced by individuals struggling with obesity.
Shares of Novo and Eli Lilly have seen a significant rise following strong indicators for the expansion of the weight loss drug market. This comes at a time when the need for effective solutions to obesity is increasingly urgent in many societies.
A recent study reveals that weight gain negatively impacts cognitive abilities as individuals age, highlighting the importance of maintaining a healthy weight to protect brain health.
Many individuals face health risks due to prolonged sitting, with some spending up to ten hours a day in this position. This habit can lead to negative effects on the body.
Researchers report that simple lifestyle changes can significantly reduce cancer risk, particularly among young people. Studies indicate that obesity may play a crucial role in rising cancer rates.
Scientists have revealed an innovative medical procedure that significantly aids in maintaining weight after ceasing the use of common diet medications. This development offers a potential alternative to ongoing pharmaceutical treatment.
GLP-1 weight loss medications have gained popularity for weight management, but improper use can diminish their effectiveness. Dr. Meena T. Malhotra warns against five common mistakes users should avoid.
The United Arab Emirates has recently approved Fondaio pills as an effective treatment for obesity, reflecting the country's efforts to tackle public health challenges. This decision comes at a time when obesity rates are rising in the region.
A recent study from Columbia University highlights the significant role of meal timing in weight loss. The findings suggest that eating at specific times can enhance dietary results.
A recent study has found that obesity is not merely a failure of willpower, but a complex health condition requiring comprehensive treatment strategies. The findings call for a reevaluation of how this growing health issue is addressed.
Abu Dhabi has announced the approval of new pills for obesity treatment as part of a comprehensive weight loss program. This initiative aims to enhance public health and reduce obesity rates in the community.
New reports indicate that the UK has recorded approximately <strong>400,000</strong> cancer cases annually, marking a concerning record. This increase is attributed to an aging population and rising obesity rates, necessitating urgent action from health authorities.
The demand for weight loss medications, particularly Ozempic, has surged since the approval of semaglutide in 2021. A recent study revealed that the use of these drugs has doubled, while bariatric surgeries have decreased by 25.6%.
A recent study from the University of Edinburgh reveals that regular yoga practice can significantly enhance heart health and metabolic indicators in individuals suffering from obesity. The findings highlight notable health benefits related to blood pressure and lipid levels.
A recent study shows that an individual's genetic makeup plays a crucial role in their response to weight loss injections, affecting both the amount of weight lost and the likelihood of side effects such as nausea.
Weight loss injections are gaining popularity, but their effectiveness varies among individuals. This discrepancy raises important questions for researchers and health professionals in the fields of nutrition and health.
Questions are rising about the link between sugar consumption and cancer. While sugar is not a direct cause, research indicates its indirect effects on risk factors.
A recent study indicates that individuals with specific genetic mutations can achieve greater weight loss when using medications like Wegovy and Mounjaro. These findings may explain the significant differences in drug efficacy among individuals.
Recent studies indicate a continuous increase in birth weights across various communities, raising concerns about children's health. This trend necessitates immediate action from stakeholders to ensure the well-being of future generations.
Daily habits can negatively impact weight, with simple behaviors leading to unnoticed weight gain. This article explores seven common habits contributing to this issue.
The United Arab Emirates has announced the acceleration of the development of new weight loss pills, raising questions about their cost and availability for patients. This announcement comes at a time when obesity rates are rising in the region.
The weight loss drug market has experienced significant transformations in recent years, with pills and injections increasingly competing to meet consumer needs. This competition reflects changing consumer preferences regarding cost and convenience.
Dr. Sanjay Bujrag, a cardiologist, warns that prolonged sitting can double the risk of heart disease. He emphasizes that a lack of movement is a major factor negatively impacting heart health.